Actively Recruiting

Age: 18Years +
All Genders
NCT06915584

Drug Management in Heart Failure

Led by IRCCS San Raffaele Roma · Updated on 2025-04-08

450

Participants Needed

1

Research Sites

39 weeks

Total Duration

On this page

Sponsors

I

IRCCS San Raffaele Roma

Lead Sponsor

A

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Collaborating Sponsor

AI-Summary

What this Trial Is About

Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts characteristics,treatment practices, adherence to prescribed guideline-based optimal drug therapy,and outcomes.The database stems from a registry started two years ago,conceived to provide a contemporary snapshot on the adherence to the latest European GGLL for the therapeutic management of pts with HF.The database will be integrated with a specifically designed algorithm that provides an accurate feedback on whether patients are properly treated according to the ESC most recent recommendations.The expected outcomes are:-define non-adherence level to GGLL-based recommendations for treatment of HF;-provide information on initiation, adherence and persistence over time of the recommended treatment;-reduce medical inertia;produce practical implications to reduce morbidity and mortality

CONDITIONS

Official Title

Drug Management in Heart Failure

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Both genders
  • Age older than 18 years
  • Signed informed consent to participate in the study
  • Known diagnosis of heart failure for more than 6 months
  • Recent or ongoing hospitalization for heart failure worsening
Not Eligible

You will not qualify if you...

  • Conditions that may interfere with the study or pose safety risks, as judged by the investigator
  • Current diagnosis of cancer (neoplasia)
  • Advanced chronic obstructive pulmonary disease with FEV1 less than 50%
  • Advanced valvular heart disease requiring cardiac surgery (severe mitral or aortic stenosis or insufficiency)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCs San Raffaele

Rome, RM, Italy, 00166

Actively Recruiting

Loading map...

Research Team

L

Lucia Gatta, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here